This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Zydus Lifesciences Limited, Cadila Healthcare Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ahmedabad, IN (2022)
- Gujarat, IN (2024)
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Mind of Sameer Agarwal
Introduction
Sameer Agarwal, an accomplished inventor based in Ahmedabad, India, has made significant contributions to the field of pharmaceuticals. With a robust portfolio consisting of three patents, Agarwal has focused his research on developing novel compounds aimed at modulating NOD-like receptor family proteins, particularly NLRP3, which are implicated in various diseases.
Latest Patents
Agarwal's latest inventions include:
1. **Substituted Sulfoximine Derivatives**: This innovation pertains to novel heterocyclic compounds characterized by a general formula (I) along with their tautomers, stereoisomers, enantiomers, and pharmaceutically acceptable salts. The invention emphasizes these compounds as NLRP3 modulators and their potential applications in treating diseases or conditions involving interleukin 1β activity and interleukin-18 (IL-18).
2. **Substituted Sulfonylurea Derivatives**: This patent involves another set of novel heterocyclic compounds represented by a general formula (I), inclusive of their pharmaceutically acceptable salts, solvates, enantiomers, diastereomers, and polymorphs. The findings indicate a strong relevance of these compounds in developing treatments for conditions linked to interleukin 1β activity, while also contributing to the understanding of NLRP3 modulation.
Career Highlights
Throughout his career, Sameer Agarwal has worked with prominent organizations such as Zydus Lifesciences Limited and Cadila Healthcare Limited. His experience at these companies has contributed significantly to his expertise in pharmaceutical innovations and patent development.
Collaborations
During his tenure in the industry, Agarwal has collaborated with esteemed colleagues, including Rajiv Sharma and Pravin Iyer. These professional relationships have fostered a shared commitment to advancing innovative pharmaceutical solutions.
Conclusion
Sameer Agarwal's dedication to pharmaceutical research and innovation exemplifies the impact of inventors in the healthcare industry. With his continued work on NLRP3 modulators and numerous patents, he is likely to play a pivotal role in the development of vital treatments for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile